- ALZN Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
Alzamend Neuro (ALZN) S-1IPO registration
Filed: 3 Jun 24, 4:30pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement and Prospectus on Form S-1 of Alzamend Neuro, Inc. of our report dated July 27, 2023 (which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern), relating to the financial statements of Alzamend Neuro, Inc., as of and for the year ended April 30, 2023.
We also consent to the reference to our firm under the heading “Experts” in such Registration Statement and Prospectus.
/s/ Baker Tilly US, LLP
San Diego, California
June 3, 2024
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.